ARCHIVES

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

Study Identifies Characteristics That Promote Early-Life NHL

May 25, 2012

Guest Commentary by Richard Rettig: Kennedy’s War On Cancer Began With National Cancer Act Of 1971.

May 23, 2008

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011

Funding opportunities listed.

February 13, 2004

New AACR Journal Avaiable Free Online Until April 15.

November 23, 2001